Contradictory to findings mentioned above, in patients with cancer undergoing PD-1 blockade, neither age nor gender was noticed to influence the development of irAE, but high BMI (BMI > 25.0) made greater odds of irAE (82). This evidence concerns the gene PDCD1 and cancer.